RF-1A Mini Manual Ampoule Ampoule Sealer & Sealing Machine

Name: RF-1A Mini Manual Ampoule Ampoule Sealer & Sealing Machine
Brand: SHANGHAI FAMO MACHINERY MANUFACTURE & TRADE CO.,LTD
SKU: 1920917962

Shanghai, ChinaSHANGHAI FAMO MACHINERY MANUFACTURE & TRADE CO.,LTD

US$700.00

1-29 Pieces

US$600.00

30+ Pieces

Product profile

Customization

Available

Warranty

1 Year

Needle Quantity

Model NO.

RF-1A

Speed

20PCS/Min

Type

Pharmaceutical Packaging Machinery

Finished Dosage Form

Liquid

Precision

Certification

GMP, ISO

Voltage

220V

Computerized

Customized

Condition

New

Transport Package

Veneer Case

Specification

ISO, SGS, CE

Trademark

Develop MC

Origin

China

HS Code

8422303090

Production Capacity

4800PCS/H

Key features

Compact and Portable Design: Small outline dimension 300*240*250mm, suitable for labs and hospitals.

High Sealing Precision: Produces sleek seals with regular thawing for ampoules 1-20ml.

Quiet and Efficient Operation: Operates with no noise and high thaw sealing speed.

GMP and ISO Certified: Meets international standards for pharmaceutical packaging machinery.

Customized Configuration: Features customized needle quantity and speed options.

Company profile

SHANGHAI FAMO MACHINERY MANUFACTURE & TRADE CO.,LTD

Shanghai, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2006-02-10 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤15h CertifiedTerms of Payment: LC, T/T CertifiedInternational Commercial Terms(Incoterms): FOB, CIF, CFR

AI-Powered supplier vetting

SummarySHANGHAI FAMO MACHINERY MANUFACTURE & TRADE CO., LTD is a China-based trading company established in 2011, focused on pharmaceutical and industrial machinery. It reports six production lines, a 56.0 m² manufacturing area, fewer than five quality-control staff, and product coverage including filling, tablet, capsule, counting, blister, and packing equipment. The supplier holds an ISO9001:2015 certificate and supports FOB, CIF, and CFR quotations. Its reported export share is 51%–70%, with broad export-market coverage and Shanghai port proximity. Evidence indicates product breadth and some international trading experience, but limited staffing, no reported R&D engineer experience, and only one year of total staff experience constrain confidence in technical depth. One identified buyer is associated with four recorded transactions in 2025.

Supplier typeThe supplier is explicitly identified as a trading company and limited company based in Shanghai, China. Its stated commercial scope covers industrial equipment, components, and manufacturing and processing machinery, while its listed products focus on pharmaceutical production and packaging equipment.

CertificationsThe supplier reports holding an ISO9001:2015 certificate for its management system. The provided information does not identify the issuing body, validity period, or certification scope, but the stated certification is explicit evidence of quality-management certification.

Production capacityThe supplier reports six production lines, a 56.0 m² manufacturing plant, fewer than five quality-control staff, and machinery covering tablet, capsule, filling, counting, blister, labeling, and packing applications. It states off-peak lead times within 15 working days but peak-season fulfillment of 2–3 months, indicating some operational capacity with potentially longer peak-period scheduling.

Customization capabilityThe company description explicitly states that it can offer options for mini, middle, and large production and even whole-factory turnkey projects. This supports a stated ability to tailor project scale and equipment combinations, although specific customization examples, engineering resources, and delivery outcomes are not documented.

Client casesTrade records identify DRUGFIELD PHARMACEUTICALS LIMITED as an associated buyer, with four recorded transactions across mixing, crushing, grinding, screening, filling, closing, sealing, or labeling machinery categories. The evidence demonstrates at least one customer relationship, but the limited number of identified buyers and transactions does not establish a broad or independently verified customer portfolio.